• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

About FDA

  • Print
  • Share
  • E-mail

Division of Medical Imaging and Hematology Products Presentations

FDA Staff Presentations at the Annual Society of Nuclear Medicine Meeting

  • Imaging Submissions to FDA: Consultative review process [PDF], Tiffany Brown, M.P.H.

  • Imaging Biomarkers and Imaging Standardization [PDF], Alexander Gorovets, M.D.

  • Highlights of Standard Meetings with the Medical Imaging Division [PDF], Kyong “Kaye” Kang, Pharm.D.

  • Chemistry, Manufacturing and Controls (CMC) for PET Drug Products [PDF], Ravindra K. Kasliwal, Ph.D.

  • Exploratory IND Studies: Pre-clinical Requirements [PDF], Tushar Kokate, Ph.D.

  • Implementation of the Exploratory IND: Medical Imaging Division Reorganization [PDF], George Mills, M.D., M.B.A.

  • The Administrative Process of Submitting Positron Emission Tomography (PET) Drug Applications [PDF], Thuy Nguyen, M.P.H.

  • The Radioactive Drug Research Committee (RDRC): A 2006 Update [PDF], Orhan H. Suleiman MS, PhD, FAAPM

  • The Study of Radioactive Drugs in Human Subjects: Radioactive Drug Research Committee (RDRC) versus Investigational New Drug (IND) [PDF] Renee Tyson